Review
Accepted on 14 May 2025
Unraveling the Immune Mechanisms and Therapeutic Targets in Lung Adenosquamous Transformation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542526
Type at least 3 characters
7,710 articles
Original Research
Accepted on 14 May 2025
Insights into Immune-Related Adverse Events in Colorectal Cancer Patients Receiving Neoadjuvant Immunotherapy: Findings from a Multicenter Registry Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529637
Original Research
Accepted on 14 May 2025
Significance of the Peripheral blood Treg/Th17 ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma and Its correlation with 1q21 Gain/Amplification
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595613
Systematic Review
Accepted on 14 May 2025
Efficacy and safety of first-line treatments for recurrent or metastatic nasopharyngeal carcinoma: a systematic review and network meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1485609
Mini Review
Published on 14 May 2025
Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1607374
Hypothesis and Theory
Accepted on 25 Apr 2025
CD44 knockdown alters miRNA expression and their target genes in colon cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1552665
- 128 views
Review
Published on 14 May 2025
Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1599908
- 184 views
Review
Published on 14 May 2025
Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1597202
- 157 views
Review
Published on 14 May 2025
Tumor-infiltrating immune cells state-implications for various breast cancer subtypes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550003
Original Research
Published on 14 May 2025
Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546371
- 215 views
Original Research
Published on 14 May 2025
Intercellular communication between FAP+ fibroblasts and SPP1+ macrophages in prostate cancer via multi-omics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560998
- 147 views
Original Research
Published on 14 May 2025
A lactate-related tSNE signature defines prognostic subtypes of bladder cancer and reveals LINC01094-mediated VIM stabilization in metastasis and drug resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1593523
- 211 views
Original Research
Published on 14 May 2025
Lung microbiome alterations correlate with immune imbalance in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1589843
Original Research
Published on 14 May 2025
Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544348
- 196 views
Original Research
Accepted on 13 May 2025
Distribution characteristics and prognostic value of TIM-1 in patients with lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1602868
Review
Accepted on 13 May 2025
Osteosarcoma Immune Microenvironment: Cellular Struggle and Novel Therapeutic Insights
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1584450